Biomarker-Oriented Therapy in Bladder and Renal Cancer

Treatment of patients with urothelial carcinoma (UC) of the bladder or renal cancer has changed significantly during recent years and efforts towards biomarker-directed therapy are being investigated. Immune checkpoint inhibition (ICI) or fibroblast growth factor receptor (FGFR) directed therapy are...

Descripción completa

Detalles Bibliográficos
Autores principales: Scholtes, Mathijs P., Alberts, Arnout R., Iflé, Iris G., Verhagen, Paul C. M. S., van der Veldt, Astrid A. M., Zuiverloon, Tahlita C. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999814/
https://www.ncbi.nlm.nih.gov/pubmed/33799514
http://dx.doi.org/10.3390/ijms22062832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999814/
https://www.ncbi.nlm.nih.gov/pubmed/33799514
http://dx.doi.org/10.3390/ijms22062832

Ejemplares similares